Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
Sun-Gi Kim (Kim SG), Byung-Kwon Kim (Kim BK), Kyumin Kim (Kim K), Sungsoon Fang (Fang S)
Endocrinol Metab. 2016;31(4):500-504.   Published online 2016 Dec 20     DOI: https://doi.org/10.3803/EnM.2016.31.4.500
Citations to this article as recorded by Crossref logo
Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis
Hongshan Li, Yingfei Xi, Xin Xin, Huajie Tian, Yiyang Hu
Nutrition & Metabolism.2020;[Epub]     CrossRef
Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies
Chang-hua Zhang, Bu-gao Zhou, Jun-qing Sheng, Yang Chen, Ying-qian Cao, Chen Chen
Pharmacological Research.2020; 159: 104984.     CrossRef
Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up‐Regulating Small Heterodimer Partner in Kupffer Cells
Dan Jin, Tianfei Lu, Ming Ni, Han Wang, Jiang Zhang, Chenpeng Zhong, Chuan Shen, Jun Hao, Ronald W. Busuttil, Jerzy W. Kupiec‐Weglinski, Jianjun Zhang, Ning Xu, Yuan Zhai
Hepatology Communications.2020; 4(4): 540.     CrossRef
Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota–bile acid–farnesoid X receptor axis
Hongshan Li, Yingfei Xi, Xin Xin, Huajie Tian, Yiyang Hu
Biomedicine & Pharmacotherapy.2020; 124: 109915.     CrossRef
An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Ke Pei, Ting Gui, Dongfang Kan, Huichao Feng, Yanqiang Jin, Ying Yang, Qian Zhang, Ziwei Du, Zhibo Gai, Jibiao Wu, Yunlun Li
BioMed Research International.2020; 2020: 1.     CrossRef
Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota
Yizhe Cui, Qiuju Wang, Renxu Chang, Xiaocui Zhou, Chuang Xu
Journal of Agricultural and Food Chemistry.2019; 67(10): 2754.     CrossRef
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters
Mao-xu Ge, Wei-xiao Niu, Jin-feng Ren, Shi-ying Cai, Dong-ke Yu, Hong-tao Liu, Na Zhang, Yi-xuan Zhang, Yu-cheng Wang, Rong-guang Shao, Ju-xian Wang, Hong-wei He
Acta Pharmacologica Sinica.2019; 40(7): 895.     CrossRef
Consenso mexicano de la enfermedad por hígado graso no alcohólico
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrer
Revista de Gastroenterología de México.2019; 84(1): 69.     CrossRef
Fish oil alleviates circadian bile composition dysregulation in male mice with NAFLD
Yang Liu, Qi Li, Hualin Wang, Xiuju Zhao, Na Li, Hongyu Zhang, Guoxun Chen, Zhiguo Liu
The Journal of Nutritional Biochemistry.2019; 69: 53.     CrossRef
Effects of sanshoamides and capsaicinoids on plasma and liver lipid metabolism in hyperlipidemic rats
Zhaojun Chen, Yongxiang Liu, Hui Wang, Zhongai Chen, Jia Liu, Hui Liu
Food Science and Biotechnology.2019; 28(2): 519.     CrossRef
The Mexican consensus on nonalcoholic fatty liver disease
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrer
Revista de Gastroenterología de México (English Edition).2019; 84(1): 69.     CrossRef
Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study
Ning Liu, Jiao Feng, Yang Lv, Qing Liu, Jingfan Deng, Yujing Xia, Chuanyong Guo, Yingqun Zhou
Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
Essential role of nuclear receptors for the evaluation of the benefits of bioactive herbal extracts on liver function
Fengling Wang, Yifan Wu, Xiaoting Xie, Jing Sun, Weidong Chen
Biomedicine & Pharmacotherapy.2018; 99: 798.     CrossRef
Maternal obesity has sex-dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring
Consuelo Lomas-Soria, Luis A. Reyes-Castro, Guadalupe L. Rodríguez-González, Carlos A. Ibáñez, Claudia J. Bautista, Laura A. Cox, Peter W. Nathanielsz, Elena Zambrano
The Journal of Physiology.2018; 596(19): 4611.     CrossRef
Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo
Lingli Zheng, Lianhong Yin, Lina Xu, Yan Qi, Hua Li, Youwei Xu, Xu Han, Kexin Liu, Jinyong Peng
Biomedicine & Pharmacotherapy.2018; 97: 481.     CrossRef
New therapeutic perspectives in non-alcoholic steatohepatitis
Javier Ampuero, Yolanda Sánchez-Torrijos, Virginia Aguilera, Francisco Bellido, Manuel Romero-Gómez
Gastroenterología y Hepatología (English Edition).2018; 41(2): 128.     CrossRef
Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD
Valerio Nobili, Anna Alisi, Antonella Mosca, Claudia Della Corte, Silvio Veraldi, Rita De Vito, Cristiano De Stefanis, Valentina D'Oria, Joerg Jahnel, Evelyn Zohrer, Eleonora Scorletti, Christopher D. Byrne
Liver International.2018; 38(2): 342.     CrossRef
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives
Stefano Gitto, Valeria Guarneri, Alessandro Sartini, Pietro Andreone
Expert Review of Gastroenterology & Hepatology.2018; 12(2): 165.     CrossRef
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
Verena Hiebl, Angela Ladurner, Simone Latkolik, Verena M. Dirsch
Biotechnology Advances.2018; 36(6): 1657.     CrossRef
Nuevas perspectivas terapéuticas en la esteatohepatitis no alcohólica
Javier Ampuero, Yolanda Sánchez-Torrijos, Virginia Aguilera, Francisco Bellido, Manuel Romero-Gómez
Gastroenterología y Hepatología.2018; 41(2): 128.     CrossRef
Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease
Qinwei Yu, Zhenzhou Jiang, Luyong Zhang
Pharmacology & Therapeutics.2018; 190: 81.     CrossRef
Hippocampal FXR plays a role in the pathogenesis of depression: A preliminary study based on lentiviral gene modulation
Wei-Guan Chen, Jia-Xuan Zheng, Xi Xu, Yu-Ming Hu, Yu-Min Ma
Psychiatry Research.2018; 264: 374.     CrossRef
Bile acid receptors and the kidney
Michal Herman-Edelstein, Talia Weinstein, Moshe Levi
Current Opinion in Nephrology and Hypertension.2018; 27(1): 56.     CrossRef
Effects of resveratrol, exercises and their combination on Farnesoid X receptor, Liver X receptor and Sirtuin 1 gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver
Amir Hajighasem, Parvin Farzanegi, Zohreh Mazaheri, Marjan Naghizadeh, Ghoncheh Salehi
PeerJ.2018; 6: e5522.     CrossRef
Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
Marco Poeta, Luca Pierri, Pietro Vajro
Children.2017; 4(8): 66.     CrossRef